#NephJC Transcript
Healthcare social media transcript of the #NephJC hashtag.
– ().
See #NephJC Influencers/Analytics.
Profile | Tweet |
---|---|
diacavan @diacavan RT @NephJC: T0a: T0a: Let’s start with a brief introduction of key facts in pre-eclampsia. ✍️ In a nutshell, here is a beautiful 🪧 infographic by @nephroseeker @KIreports #NephJC https://t.co/6JNeWOKxYu | |
diacavan @diacavan RT @NephJC: T0f: T0f: Understand the factors 1st PlGF the good fella👍 ☑️ proangiogenic(P for “pro”) ☑️ role in angiogenesis,vasculogenesis,embryogenesis sFlt-1 the bad one👎 ☑️ produced due to placental hypoxia ☑️ Antiangiogenic factor, binds VEGF-A/B & PlGF ☑️ ⬇️free VEGF ⬇️angiogenesis #NephJC https://t.co/SWMMHlPa1G | |
diacavan @diacavan RT @NephJC: T1e : T1e : Primary endpoint was development of severe PE (sPE) within two weeks of enrollment 📈 👇To know what sPE means, take a glance at this amazing infographic by @elbaonelida ! #NephJC https://t.co/xw6NdPDh0z | |
diacavan @diacavan RT @NephJC: T0e: T0e: Pathophysiology of pre-eclampsia ⚖️Central event is imbalance between angiogenic and antiangiogenic factors #NephJC 👇The overview of pre-eclampsia pathogenesis from @ASNKidney360 ✍️By @divyaa24 @silvishah @NephroSeeker @DrSandiDumanski 🔗https://t.co/qyEFbptmzD https://t.co/p3Prda7d5A | |
diacavan @diacavan RT @NephJC: T2h:How does sFlt-1:PIGF Ratio fare in predicting sPE over next 2w vs other SOC tests? 🔥AUC of ratio = 0.92 👎For all others AUC <0.75 ⚖️Adjustment for gestational age, SBP, biochem tests did not improve accuracy The ratio remained the OG here!! 😈😈 #NephJC VA by @divyaa24 https://t.co/Z09p1ISrot | |
Mahmoud Kareem @Mahmoud33986639 RT @NephJC: T0e: T0e: Pathophysiology of pre-eclampsia ⚖️Central event is imbalance between angiogenic and antiangiogenic factors #NephJC 👇The overview of pre-eclampsia pathogenesis from @ASNKidney360 ✍️By @divyaa24 @silvishah @NephroSeeker @DrSandiDumanski 🔗https://t.co/qyEFbptmzD https://t.co/p3Prda7d5A | |
diacavan @diacavan RT @NephJC: T0d: T0d: #NephJC @Kidney_Int meta-analysis showed risk of end-stage kidney disease after preeclampsia was significant ⬆️: meta-analytic risk ratios, 95% CI, 6.35 (2.73-14.79) By @gb_piccoli @LoretoGesualdo https://t.co/EW2WE6OdqL https://t.co/tDOOtgXGyM | |
diacavan @diacavan RT @NephJC: T0b: T0b: ⬆️ Obesity and chronic hypertension, assisted fertility ➡️ increase in rates of Pre-eclampsia 🤰🏽⚡ ☑️ Black and Hispanic women > 2 times risk #NephJC 👇here is an overview of the most important risk factors. Familiar, no? @Kireports @NephroSeeker https://t.co/O0pNWQ80HV https://t.co/rJqKHnNl2m | |
soda_troubles,https://med-mastodon.com/@haysam @set_fortess RT @NephJC: T2c : T2c : sFlt-1:PlGF ratio >40 had 81% sensitivity (95% CI, 70 to 90) 81% specificity (95% CI, 74 to 87) PPV of 66% (95% CI, 55 to 76) NPV of 90%(95% CI, 84 to 95) 🤩 👍! Ratio >40 further tested in validation cohort #NephJC | |
Shubharthi Kar, MD, FISN @shubharthikar RT @NephJC: T0c: T0c: Don't take preeclampsia easy! 💔It comes with scary and unwanted outcomes: higher CV burden, CKD ... you'd naively say, for more than 50% of 🌐 population, but think twice, because there are also risks for the 👶 #NephjC @ASNKidney360 https://t.co/qyEFbptmzD https://t.co/2r76VoCs4R | |
ValerioCoronel @vacorogo Excelente artículo | |
Dr Benil @hafeeq_benil RT @NephJC: T0d: T0d: #NephJC @Kidney_Int meta-analysis showed risk of end-stage kidney disease after preeclampsia was significant ⬆️: meta-analytic risk ratios, 95% CI, 6.35 (2.73-14.79) By @gb_piccoli @LoretoGesualdo https://t.co/EW2WE6OdqL https://t.co/tDOOtgXGyM | |
Kajaree Giri @KajareeG RT @NephJC: #NephJC this week to support #Nephmadness #PreEclampsiaRegion! Summary: https://t.co/6mepnJGUe3 from @elbaonelida and @Kavitasv20 Visual Abstract from @elbaonelida (with some bonus VAs from @divyaa24 !) https://t.co/3HLxFbtnxd | |
diacavan @diacavan RT @NephJC: #NephJC this week to support #Nephmadness #PreEclampsiaRegion! Summary: https://t.co/6mepnJGUe3 from @elbaonelida and @Kavitasv20 Visual Abstract from @elbaonelida (with some bonus VAs from @divyaa24 !) https://t.co/3HLxFbtnxd | |
Pallavi Prasad MD DNB @DrPallaviPrasad @tanujlamech @NephJC @kidney_boy @MChanMD @brian_rifkin And like FLC removal in MM #NephJC Drawing analogies from that, the only answer is termination of pregnancy ( we already know that).Or correction of abnormal placentation ( still gotta explore how to do that one 😄) #NephJC | |
Beatriz Fernandez Fernandez @beaff26 RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
Beatriz Fernandez Fernandez @beaff26 RT @NephJC: T0a: T0a: Let’s start with a brief introduction of key facts in pre-eclampsia. ✍️ In a nutshell, here is a beautiful 🪧 infographic by @nephroseeker @KIreports #NephJC https://t.co/6JNeWOKxYu | |
manuel macia heras @mmacia25 RT @NephJC: T0a: T0a: Let’s start with a brief introduction of key facts in pre-eclampsia. ✍️ In a nutshell, here is a beautiful 🪧 infographic by @nephroseeker @KIreports #NephJC https://t.co/6JNeWOKxYu | |
Sai Charan Vedula @SaiVedulaMD RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
Santiago Moreno T. @santy431 👏🏻👏🏻👏🏻👏🏻 | |
Shilpa Jesudason @shilpa_jes RT @NephJC: T0a: T0a: Let’s start with a brief introduction of key facts in pre-eclampsia. ✍️ In a nutshell, here is a beautiful 🪧 infographic by @nephroseeker @KIreports #NephJC https://t.co/6JNeWOKxYu | |
Nephrology Journal Club @NephJC Join us for #NEPHJC ASIA. It begins at 9pm IST [2hrs from now] | |
NephMadness @NephMadness RT @NephJC: T0g: T0g: About the most common GN in the world and preeclampsia... Don't take our word for granted! We just mention, that the same thing was said in @ISGDtweets podcast #NephMadness #NephJC 🎙️Hear it yourself from @kdjhaveri @koyaljainMD @anna_burgner https://t.co/y1oiJiJrLb | |
NephMadness @NephMadness RT @kidneyrebel: “#NephMadness 2024: “#NephMadness 2024: Preeclampsia – For Pregnant People Everywhere, it’s Diagnosis for the Win” by @AndreaOliverio “Overall, this is a close match-up…” Commentary posted just in time for the #NephJC on the topic. https://t.co/keFr9fuPQr | |
Anant SSP MD DM 🇮🇳 @Glomkeeper RT @NephJC: Join us for #NEPHJC ASIA. It begins at 9pm IST [2hrs from now] | |
Anant SSP MD DM 🇮🇳 @Glomkeeper Joining #Nephjc today PRE-ECLAMPSIA learning feast with @divyaa24 No COI #NephMadness | |
Joshua Waitzman, MD PhD @Jwaitz @brian_rifkin @NephJC Why is troponin everywhere and sFlt/PIGF nowhere? In other words... #nephjc https://t.co/JwTqXIcMyA | |
Mana @manasigh RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
Jasmine Sethi @JasmineNephro 🤰Hypertensive disorders of pregnancy @NephJC 👇 | |
[Lupinina Lupinus ] @magutrejo RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
Swapnil Hiremath @hswapnil@bsky.social @hswapnil RT @NephJC: Join us for #NEPHJC ASIA. It begins at 9pm IST [2hrs from now] | |
[Lupinina Lupinus ] @magutrejo RT @NephJC: T0e: T0e: Pathophysiology of pre-eclampsia ⚖️Central event is imbalance between angiogenic and antiangiogenic factors #NephJC 👇The overview of pre-eclampsia pathogenesis from @ASNKidney360 ✍️By @divyaa24 @silvishah @NephroSeeker @DrSandiDumanski 🔗https://t.co/qyEFbptmzD https://t.co/p3Prda7d5A | |
Gustavo Leal @nefrocabra RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
Renal Failure @RenalFailureTF RT @NephJC: T0b: T0b: ⬆️ Obesity and chronic hypertension, assisted fertility ➡️ increase in rates of Pre-eclampsia 🤰🏽⚡ ☑️ Black and Hispanic women > 2 times risk #NephJC 👇here is an overview of the most important risk factors. Familiar, no? @Kireports @NephroSeeker https://t.co/O0pNWQ80HV https://t.co/rJqKHnNl2m | |
NephSIM @Neph_SIM RT @anna_burgner: Don't forget time is running out to put in your #nephmadness brackets! After this #nephjc chat make sure to go to https://t.co/kp5cTnjLOD to submit your 2 brackets! | |
Dr Kavita Vishwakarma @Kavitasv20 RT @NephJC: Join us for #NEPHJC ASIA. It begins at 9pm IST [2hrs from now] | |
Dr Nikhil J @DrNikhilJ1 RT @NephJC: T1b: T1b: Recapping how preeclampsia and other hypertensive disorders of pregnancy were defined by @ACOGPregnancy ❣️Remider: proteinuria is not mandatory for PE diagnosis #NephJC https://t.co/902pUGrUxC | |
Gargi 🏳️⚧️🏳️🌈 @Doctor_Gargi RT @JasmineNephro: 🤰Hypertensive disorders of pregnancy @NephJC 👇 | |
Milagros Flores @dra_miliflores RT @NephJC: #NephJC this week to support #Nephmadness #PreEclampsiaRegion! Summary: https://t.co/6mepnJGUe3 from @elbaonelida and @Kavitasv20 Visual Abstract from @elbaonelida (with some bonus VAs from @divyaa24 !) https://t.co/3HLxFbtnxd | |
Nephrology Journal Club @NephJC New to #NephJC? We are glad to have you here! Just read the instructions 👇and you are good to go! Don’t forget to introduce yourself, interact and include #NephJC in all ur tweets! Also, always be courteous to others 📷 https://t.co/M72qbCVgCX | |
Nephrology Journal Club @NephJC Check out the STUNNING visual abstracts by @elbaonelida & @divyaa24 https://t.co/RQ3Ss6TR8O… #NephJC https://t.co/lcYiKOxlf3 | |
Swapnil Hiremath @hswapnil@bsky.social @hswapnil RT @NephJC: Check out the STUNNING visual abstracts by @elbaonelida & @divyaa24 https://t.co/RQ3Ss6TR8O… #NephJC https://t.co/lcYiKOxlf3 | |
Swapnil Hiremath @hswapnil@bsky.social @hswapnil RT @NephJC: New to #NephJC? We are glad to have you here! Just read the instructions 👇and you are good to go! Don’t forget to introduce yourself, interact and include #NephJC in all ur tweets! Also, always be courteous to others 📷 https://t.co/M72qbCVgCX | |
Nephrology Journal Club @NephJC Welcome to tonight’s discussion on 🔥Utility of circulating angiogenic factors in #Preeclampsia🔥 I am Divya Bajpai @divyaa24, your host for tonight, from Mumbai, India. No COI other than I absolutely ❤️ everything related to obstetric nephrology #NephJC https://t.co/P3GIKiUTu8 | |
shahin mohammed @shahsonride hi its shahin. Excited to learn regarding more about preeclampsia. No COI. will be lurking around #NephJc | |
Nephrology Journal Club @NephJC Lets begin with taking a simple poll on #preeclampsia prediction #Nephjc | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 RT @NephJC: Welcome to tonight’s discussion on 🔥Utility of circulating angiogenic factors in #Preeclampsia🔥 I am Divya Bajpai @divyaa24, your host for tonight, from Mumbai, India. No COI other than I absolutely ❤️ everything related to obstetric nephrology #NephJC https://t.co/P3GIKiUTu8 | |
Nephrology Journal Club @NephJC Preeclampsia is truly the most common glomerular d/o in 🌎, not IgAN! 📷 most unrecognized glomerular injury in the world 🇮🇳The incidence of preeclampsia in hospital practice in India varies from 5% to 15%, and that of eclampsia is about 1.5%. #nephjc https://t.co/5MsIV3Q9kE. https://t.co/dMUyl7ngYb | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 @NephroSeeker @NephJC Your lurking is also great 👍🙏🏼 #nephjc | |
Nephrology Journal Club @NephJC Guess what they called pre-eclampsia in the 1800s? Bright’s disease in pregnancy ! #NephJC also, 👀 Check out this beautiful image 📷 telling a tale of pre eclampsia in 1800s "Cases of puerperal convulsions" https://t.co/ulx1t1kXI6 | |
nyiminhan @nyiminhan Hello everyone, this is Han, Nephrologist from Myanmar, No COIs #NephJC https://t.co/MgmdDlPIBr | |
Bayar Jaff @JaffBayar RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
Sowrabha Rajanna @dr_sourabha Hi #NephJC Sowrabha joining from Mysore. Lurking tonight | |
Nephrology Journal Club @NephJC @nyiminhan welcome please tell ur experience with #preeclampsia #nephjc | |
Nephrology Journal Club @NephJC These are the abbreviations that we will be using: Pre eclampsia = PE Severe Pre eclampsia = sPE Soluble FMS tyrosine kinase 1 = sFlt-1 Placental growth factor = PlGF #NephJC | |
Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi Hi all, this is Arvind Canchi Bangalore based Nephrologist at the #nephjc. The cost of the test in India 👇 https://t.co/8ZEbnP8awD | |
Nephrology Journal Club @NephJC @arvindcanchi welcome please tell ur experience with #preeclampsia #nephjc How have been outcomes lately? | |
Nephrology Journal Club @NephJC Here is the link to the main study #NephJC https://t.co/IPpgqZg8nE… Do we have the authors with us here? Tagging them here to let them know ! @sarah_sjk @ananthmsn34 #NephJC | |
Nephrology Journal Club @NephJC RT @arvindcanchi: Hi all, this is Arvind Canchi Bangalore based Nephrologist at the #nephjc. The cost of the test in India 👇 https://t.co/8ZEbnP8awD | |
Dilushi Wijayaratne @Dilushiwijay Hi this is Dilushi, nephrologist, lurking from Colombo.. No COI #NephJC | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 This test in India can cost around rs 4500 to 6000 Kem pune is also doing it #nephjc https://t.co/OuAMhH6ylr | |
Nephrology Journal Club @NephJC @Dilushiwijay welcome on board #nephjc | |
Dr. Hardik Patel 🩺💉 @hardik4u24 Hi , I am Hardik patel , Nephrology Resident , India. Looking forward to learn about newer biomarker for pre eclampsia diagnosis . .Would be lurking around . No COI #NephJc | |
Pallavi Prasad MD DNB @DrPallaviPrasad Hi all! Pallavi from New Delhi. Lurking tonite. No COI #NephJC | |
Dilushi Wijayaratne @Dilushiwijay RT @NephJC: Here is the link to the main study #NephJC https://t.co/IPpgqZg8nE… Do we have the authors with us here? Tagging them here to let them know ! @sarah_sjk @ananthmsn34 #NephJC | |
Nephrology Journal Club @NephJC @DrPallaviPrasad welcome aboard #nephjc | |
Nephrology Journal Club @NephJC @hardik4u24 welcome aboard #nephjc | |
Pallavi Prasad MD DNB @DrPallaviPrasad @arvindcanchi Sir i think it would also be important to know the turn around time! #NephJC | |
Shreshta Tripathi @ShreshtaT 🤰Excited for tonight’s #NephJC discussing “Pre-eclampsia” 🔍Look forward to more insight on this topic No COI! | |
Dr Nikhil J @DrNikhilJ1 Hi, this is Nikhil, from Bengaluru. Interested to learn more about pre eclampsia. No COI #NephJC | |
Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi @NephJC My wife @ba_roopa is an Ob&G specialist. She does treat high risk pregnancies. I asked her if she had used this test the sflt-1 :PIGF ratio in pre eclampsia pts and she said no, she uses clinical indices and uterine artery doppler. #nephjc | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 Pregnancy hypertension incidence was lower in Pakistan (9.3%) than India (10.3%), Mozambique (10.9%), or Nigeria (10.2%) (p = 0.001). Most hypertension was diastolic only (46.4% in India, 72.7% in Pakistan, 61.3% in Mozambique, and 63.3% in Nigeria https://t.co/yLO67j9D8M #nephjc | |
AS @Ren_Familia Hello everyone. Anitha here, nephrologist from Hyderabad #NephJC | |
Nephrology Journal Club @NephJC T0b: ⬆️ Obesity and chronic hypertension, assisted fertility ➡️ increase in rates of Pre-eclampsia 🤰🏽📷⚡ Black and Hispanic women > 2 times risk #NephJC here is an overview of the most important risk factors. Familiar, no? @Kireports @NephroSeeker https://t.co/2pjXo0bbrT https://t.co/1KYFZJSxdS | |
Elba Medina @elbaonelida RT @NephJC: Check out the STUNNING visual abstracts by @elbaonelida & @divyaa24 https://t.co/RQ3Ss6TR8O… #NephJC https://t.co/lcYiKOxlf3 | |
Nephrology Journal Club @NephJC @arvindcanchi @ba_roopa we also do the same. But our colleagues from 🇺🇸🇨🇦 are using quite routinely #nephjc | |
Vamsidhar Veeranki @VamsidharV17 Hi..this is vamsi from India..no COI #NephJC | |
nyiminhan @nyiminhan RT @NephJC: T0b: T0b: ⬆️ Obesity and chronic hypertension, assisted fertility ➡️ increase in rates of Pre-eclampsia 🤰🏽📷⚡ Black and Hispanic women > 2 times risk #NephJC here is an overview of the most important risk factors. Familiar, no? @Kireports @NephroSeeker https://t.co/2pjXo0bbrT https://t.co/1KYFZJSxdS | |
Nephrology Journal Club @NephJC T0d: #NephJC @Kidney_Int meta-analysis showed risk of end-stage kidney disease after preeclampsia was significant ⬆️: meta-analytic risk ratios, 95% CI, 6.35 (2.73-14.79) By @gb_piccoli @LoretoGesualdo https://t.co/ISRmtxQ3lW https://t.co/ZALbaoBYb2 | |
Nephrology Journal Club @NephJC T0c: Don't take preeclampsia easy! 💔It comes with scary outcomes: higher CV burden, CKD .you'd naively say, for more than 50% of 🌐 population, but think twice, because there are also risks for the 👶#NephjC ✍️by @divyaa24 @silvishah @ASNKidney360 https://t.co/qyEFbptmzD https://t.co/yosQvDkx6K | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 https://t.co/khvQOUzPQX Maternal mortality in India #nephjc https://t.co/evut4UWYvt | |
Milagros Flores @dra_miliflores Milagros 🇭🇳, live from Mexico 🇲🇽, lurking 👀 between the practice, X space On the Road to #ISNWCN & eager 🤩 to learn #PreEclampsiaRegion #NephMadness #NephJC Coffee ☕️ is really needed 🥰 https://t.co/PAm1q2sm1q | |
Nephrology Journal Club @NephJC T0e: Pathophysiology of pre-eclampsia ⚖️Central event is imbalance between angiogenic and antiangiogenic factors #NephJC 🌟The overview of pre-eclampsia pathogenesis from @ASNKidney360 ✍️@divyaa24 @silvishah @NephroSeeker @DrSandiDumanski 🔗https://t.co/qyEFbptmzD https://t.co/iD5BxpXW6u | |
Nephrology Journal Club @NephJC T0f: Understand the factors 1st PlGF the good fella👍 ☑️ proangiogenic(P for “pro”) 🌟role in angiogenesis,vasculogenesis,embryogenesis sFlt-1 the bad one 🌟produced due to placental hypoxia 🌟Antiangiogenic factor, binds VEGF-A/B & PlGF ⬇️free VEGF ⬇️angiogenesis #NephJC https://t.co/JmqRj7caZr | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 @dra_miliflores Welcome aboard #nephjc Do u use angiogenic markers? | |
Dr Kavita Vishwakarma @Kavitasv20 @NephJC @divyaa24 Hi @divyaa24, Kavita from Mumbai, Lurking! No COI! #NephJC https://t.co/HZMsU2lvoI | |
Brammah Thanga @brammahin Brammah from Sri Lanka.Joining in late, NO COI #Nephjc | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 2/3 death= severe bleeding (typically occurring after childbirth), infections (commonly arising after childbirth), high blood pressure during pregnancy (pre-eclampsia and eclampsia), delivery-related complications, and unsafe abortions. #nephjc | |
Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi Recent Study from Lucknow #nephjc 💥Women who had adverse maternal events had higher median maternal concentrations of soluble fms-like tyrosine kinase (11,500.0 pg/mL vs 3051.0 pg/mL; P<.001), lower concentrations of placental growth factor (44.88 pg/mL vs 148.50 pg/mL;… https://t.co/nYexDVwZm1 | |
Nephrology Journal Club @NephJC RT @arvindcanchi: Recent Study from Lucknow #nephjc 💥Women who had adverse maternal events had higher median maternal concentrations of soluble fms-like tyrosine kinase (11,500.0 pg/mL vs 3051.0 pg/mL; P<.001), lower concentrations of placental growth factor (44.88 pg/mL vs 148.50 pg/mL;… https://t.co/nYexDVwZm1 | |
Dr Nikhil J @DrNikhilJ1 RT @NephJC: T0e: T0e: Pathophysiology of pre-eclampsia ⚖️Central event is imbalance between angiogenic and antiangiogenic factors #NephJC 🌟The overview of pre-eclampsia pathogenesis from @ASNKidney360 ✍️@divyaa24 @silvishah @NephroSeeker @DrSandiDumanski 🔗https://t.co/qyEFbptmzD https://t.co/iD5BxpXW6u | |
Nephrology Journal Club @NephJC @brammahin welcome to #nephjc asia | |
Nephrology Journal Club @NephJC @Kavitasv20 @divyaa24 welcome great work on summary #nephjc | |
Nephrology Journal Club @NephJC RT @divyaa24: https://t.co/khvQOUzPQX Maternal mortality in India #nephjc https://t.co/evut4UWYvt | |
Nephrology Journal Club @NephJC RT @divyaa24: Pregnancy hypertension incidence was lower in Pakistan (9.3%) than India (10.3%), Mozambique (10.9%), or Nigeria (10.2%) (p = 0.001). Most hypertension was diastolic only (46.4% in India, 72.7% in Pakistan, 61.3% in Mozambique, and 63.3% in Nigeria https://t.co/yLO67j9D8M #nephjc | |
Dr Kavita Vishwakarma @Kavitasv20 RT @divyaa24: Pregnancy hypertension incidence was lower in Pakistan (9.3%) than India (10.3%), Mozambique (10.9%), or Nigeria (10.2%) (p = 0.001). Most hypertension was diastolic only (46.4% in India, 72.7% in Pakistan, 61.3% in Mozambique, and 63.3% in Nigeria https://t.co/yLO67j9D8M #nephjc | |
Nephrology Journal Club @NephJC Time for another POLL. Please Vote #nephjc | |
Elba Medina @elbaonelida RT @arvindcanchi: Recent Study from Lucknow #nephjc 💥Women who had adverse maternal events had higher median maternal concentrations of soluble fms-like tyrosine kinase (11,500.0 pg/mL vs 3051.0 pg/mL; P<.001), lower concentrations of placental growth factor (44.88 pg/mL vs 148.50 pg/mL;… https://t.co/nYexDVwZm1 | |
Milagros Flores @dra_miliflores @divyaa24 Not for routine use … only by request under a scientific investigation #NephJC | |
Nephrology Journal Club @NephJC T0g: About the most common GN in the world and preeclampsia... Don't take our word for granted! We just mention, that the same thing was said in @ISGDtweets podcast #NephMadness #NephJC 🎙️Hear it yourself from @kdjhaveri @koyaljainMD @anna_burgner https://t.co/y1oiJiJrLb | |
Dr Kavita Vishwakarma @Kavitasv20 @NephJC @divyaa24 Thank you @divyaa24 for constant support and encouragement! #NephJC | |
Nephrology Journal Club @NephJC T0h: These sFlt-1 & PlGF essays ☑️ commercially available in Europe Not freely in 🇮🇳 only as researchtool ☑️ studied in large prospective cohort studies like PROGNOSIS and SaPPPhire ☑️ aid identify pregnant women at severe risk of preeclampsia #NephJC https://t.co/l3spyqMylx | |
Dr Kavita Vishwakarma @Kavitasv20 RT @arvindcanchi: Recent Study from Lucknow #nephjc 💥Women who had adverse maternal events had higher median maternal concentrations of soluble fms-like tyrosine kinase (11,500.0 pg/mL vs 3051.0 pg/mL; P<.001), lower concentrations of placental growth factor (44.88 pg/mL vs 148.50 pg/mL;… https://t.co/nYexDVwZm1 | |
Dr Kavita Vishwakarma @Kavitasv20 RT @divyaa24: 2/3 death= severe bleeding (typically occurring after childbirth), infections (commonly arising after childbirth), high blood pressure during pregnancy (pre-eclampsia and eclampsia), delivery-related complications, and unsafe abortions. #nephjc | |
Nephrology Journal Club @NephJC T0i: More than 2 studies were asking the same question: is sFLT1/PIGF suited to diagnose PE? #NephJC 🔎PROGNOSIS study provided ⬆️negative predictive value to predict the absence of preeclampsia with an sFlt-1:PIGF ratio of 38 or lower @elbaonelida @Kavitasv20 @NephroSeeker https://t.co/OVLBn2k2Mg | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 Today I was taking a lecture for MD med students When I told them #preeclampsia is the most common GN Everyone was surprised We should be teaching more OBSTETRIC NEPHROLOGY in MBBS/MD #nephjc | |
Dr Kavita Vishwakarma @Kavitasv20 RT @NephJC: T0i: More than 2 studies were asking the same question: T0i: More than 2 studies were asking the same question: is sFLT1/PIGF suited to diagnose PE? #NephJC 🔎PROGNOSIS study provided ⬆️negative predictive value to predict the absence of preeclampsia with an sFlt-1:PIGF ratio of 38 or lower @elbaonelida @Kavitasv20 @NephroSeeker https://t.co/OVLBn2k2Mg | |
Nephrology Journal Club @NephJC T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🫘Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/2pjXo0aDCl https://t.co/Wtmqqpp8aP | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 @Kavitasv20 @NephJC You are awesome #nephjc https://t.co/kTOC7dsLPW | |
Dr Nikhil J @DrNikhilJ1 RT @NephJC: T0c: T0c: Don't take preeclampsia easy! 💔It comes with scary outcomes: higher CV burden, CKD .you'd naively say, for more than 50% of 🌐 population, but think twice, because there are also risks for the 👶#NephjC ✍️by @divyaa24 @silvishah @ASNKidney360 https://t.co/qyEFbptmzD https://t.co/yosQvDkx6K | |
Nephrology Journal Club @NephJC RT @divyaa24: Today I was taking a lecture for MD med students When I told them #preeclampsia is the most common GN Everyone was surprised We should be teaching more OBSTETRIC NEPHROLOGY in MBBS/MD #nephjc | |
Nephrology Journal Club @NephJC T0k: Would this help in ❓a potential reduction in hospitalizations in 🇮🇳 ? are there targeted treatments ? can we have better resource allocation #nephjc | |
Nephrology Journal Club @NephJC RT @anna_burgner: @NephJC @ISGDtweets @kdjhaveri @koyaljainMD The #NephMadness post also references it with citations: @NephJC @ISGDtweets @kdjhaveri @koyaljainMD The #NephMadness post also references it with citations: https://t.co/wM28xE7Q2U #NephJC | |
Dr Kavita Vishwakarma @Kavitasv20 RT @divyaa24: Today I was taking a lecture for MD med students When I told them #preeclampsia is the most common GN Everyone was surprised We should be teaching more OBSTETRIC NEPHROLOGY in MBBS/MD #nephjc | |
shahin mohammed @shahsonride RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🫘Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/2pjXo0aDCl https://t.co/Wtmqqpp8aP | |
shahin mohammed @shahsonride RT @NephJC: T0g: T0g: About the most common GN in the world and preeclampsia... Don't take our word for granted! We just mention, that the same thing was said in @ISGDtweets podcast #NephMadness #NephJC 🎙️Hear it yourself from @kdjhaveri @koyaljainMD @anna_burgner https://t.co/y1oiJiJrLb | |
Dr Kavita Vishwakarma @Kavitasv20 RT @anna_burgner: @NephJC @ISGDtweets @kdjhaveri @koyaljainMD The #NephMadness post also references it with citations: @NephJC @ISGDtweets @kdjhaveri @koyaljainMD The #NephMadness post also references it with citations: https://t.co/wM28xE7Q2U #NephJC | |
Nephrology Journal Club @NephJC T0l: #NephJC sFLT1:PIGF use in European maternity clinics led to: 💚improvement in triaging 🤰 at severe risk of PE in need of in-patient admissions 45-55%⬇️ in need of in-patient admissions 💸£24 million reduction in expected annual costs for the UK NHS https://t.co/iY6HKslluR https://t.co/1XBlqMzxNe | |
Elba Medina @elbaonelida RT @NephJC: T0i: More than 2 studies were asking the same question: T0i: More than 2 studies were asking the same question: is sFLT1/PIGF suited to diagnose PE? #NephJC 🔎PROGNOSIS study provided ⬆️negative predictive value to predict the absence of preeclampsia with an sFlt-1:PIGF ratio of 38 or lower @elbaonelida @Kavitasv20 @NephroSeeker https://t.co/OVLBn2k2Mg | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 This can especially help in resource limited settings where early detection and timely hospitalisation may save 💰 Also in govt hospital with bed crunch this will help But important to NOT timing of delivery decisions on solely this #nephjc | |
Nephrology Journal Club @NephJC T1 a': #NephJC ✨Multicenter 📷Triple blinded 📷Prospective study 🔥 2 parts- derivation study & validation study @NEJMEvidence https://t.co/8NJX9COzN6 https://t.co/QvcM4uhan4 | |
Nephrology Journal Club @NephJC T1a: The PRACEIS trial (Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification) ☑️ Largest US trial till date ☑️First of its kind 📷Multi-centre with Demographically diverse cohort #NephJC🤰🏼 | |
Elba Medina @elbaonelida RT @NephJC: T1a: The PRACEIS trial (Preeclampsia Risk Assessment: T1a: The PRACEIS trial (Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification) ☑️ Largest US trial till date ☑️First of its kind 📷Multi-centre with Demographically diverse cohort #NephJC🤰🏼 | |
Nephrology Journal Club @NephJC RT @divyaa24: This can especially help in resource limited settings where early detection and timely hospitalisation may save 💰 Also in govt hospital with bed crunch this will help But important to NOT timing of delivery decisions on solely this #nephjc | |
Milagros Flores @dra_miliflores @NephJC It could help to advocate in many more regions #NephJC https://t.co/Vsn8lmH7bi | |
Nephrology Journal Club @NephJC @elbaonelida @Kavitasv20 @divyaa24 welcome Elba great work with VA #nephjc | |
Elba Medina @elbaonelida RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🫘Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/2pjXo0aDCl https://t.co/Wtmqqpp8aP | |
Nephrology Journal Club @NephJC T1b: Recapping how preeclampsia and other hypertensive disorders of pregnancy were defined by @ACOGPregnancy ❣️Remider: proteinuria is not mandatory for PE diagnosis #NephJC https://t.co/rjlbhHE1jk | |
Brammah Thanga @brammahin RT @NephJC: T1b: T1b: Recapping how preeclampsia and other hypertensive disorders of pregnancy were defined by @ACOGPregnancy ❣️Remider: proteinuria is not mandatory for PE diagnosis #NephJC https://t.co/rjlbhHE1jk | |
Nephrology Journal Club @NephJC T1c: Sample size calculation of derivation and validation cohorts were derived as follows👇 #NephJC https://t.co/v29kpxB7df | |
Dr Kavita Vishwakarma @Kavitasv20 RT @divyaa24: This can especially help in resource limited settings where early detection and timely hospitalisation may save 💰 Also in govt hospital with bed crunch this will help But important to NOT timing of delivery decisions on solely this #nephjc | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 ASIAN DATA sFlt-1/PlGF ratio cutoff of 38 demonstrated clinical value for the short-term prediction of preeclampsia in Asian women with suspected preeclampsia, potentially helping to prevent unnecessary hospitalization and intervention. https://t.co/ZXUSUeBL7U #nephjc | |
Nephrology Journal Club @NephJC T1e : Primary endpoint was development of severe PE (sPE) within two weeks of enrollment 📈 To know what sPE means, take a glance at this amazing infographic by @elbaonelida ! #NephJC https://t.co/qOciMn8ZYy | |
Elba Medina @elbaonelida @NephJC @Kavitasv20 @divyaa24 I am agree with @Kavitasv20 thank you for constant support and encouragement! #NephJC ✨ https://t.co/D2AMAjJu8N | |
Dr Kavita Vishwakarma @Kavitasv20 @NephJC They didnnot mention if the women were diabetics/ GDM or obese or had underlying GN #NephJC | |
Nephrology Journal Club @NephJC T1f : The Secondary outcomes were a composite of adverse maternal 🤱, fetal 👶 outcomes and the performance 🎲 of sFLT-1/PlGF ratio #NephJC https://t.co/CmO0TSWCFh | |
sejal kotwani @KotwaniSejal RT @divyaa24: ASIAN DATA sFlt-1/PlGF ratio cutoff of 38 demonstrated clinical value for the short-term prediction of preeclampsia in Asian women with suspected preeclampsia, potentially helping to prevent unnecessary hospitalization and intervention. https://t.co/ZXUSUeBL7U #nephjc | |
Nephrology Journal Club @NephJC RT @divyaa24: ASIAN DATA sFlt-1/PlGF ratio cutoff of 38 demonstrated clinical value for the short-term prediction of preeclampsia in Asian women with suspected preeclampsia, potentially helping to prevent unnecessary hospitalization and intervention. https://t.co/ZXUSUeBL7U #nephjc | |
Elba Medina @elbaonelida RT @NephJC: T1e : T1e : Primary endpoint was development of severe PE (sPE) within two weeks of enrollment 📈 To know what sPE means, take a glance at this amazing infographic by @elbaonelida ! #NephJC https://t.co/qOciMn8ZYy | |
Nephrology Journal Club @NephJC T1g- Let's recap the study! #NephJC infographic by @elbaonelida https://t.co/dgSGu1QQYC | |
Nephrology Journal Club @NephJC @elbaonelida @Kavitasv20 @divyaa24 you did all the hard work #nephjc https://t.co/jZfMZe0Mqk | |
Dr Kavita Vishwakarma @Kavitasv20 @NephroSeeker @NephJC @divyaa24 @silvishah @ASNKidney360 Toxicity that prevails long term #NephJC https://t.co/qFn233Bh7U | |
Dr Kavita Vishwakarma @Kavitasv20 @NephJC @elbaonelida @divyaa24 #nephJC https://t.co/RiEAbysMXB | |
Nephrology Journal Club @NephJC Are you ready for results? To highlight the importance, keep in mind all the nasty PE outcomes 👇Here is a pic for emphasis #NephJC https://t.co/HbIEPrBu5U | |
Milagros Flores @dra_miliflores @NephJC @elbaonelida @Kavitasv20 @divyaa24 #NephJC https://t.co/hmjdd44oEK | |
Sarath శరత్🚵 @sarathuniverse RT @divyaa24: Today I was taking a lecture for MD med students When I told them #preeclampsia is the most common GN Everyone was surprised We should be teaching more OBSTETRIC NEPHROLOGY in MBBS/MD #nephjc | |
Nephrology Journal Club @NephJC T2a: Coming to the results 👍 Notably, the study population🚺 epresented broadly the population of 🤰🏽with Hypertension in 🇺🇸#NephJC https://t.co/CnQJ7VBrCn | |
Milagros Flores @dra_miliflores @NephJC #NephJC 😝 😍 https://t.co/HYhfmYTetd | |
Elba Medina @elbaonelida RT @NephJC: T2a: T2a: Coming to the results 👍 Notably, the study population🚺 epresented broadly the population of 🤰🏽with Hypertension in 🇺🇸#NephJC https://t.co/CnQJ7VBrCn | |
Dr. Divya Bajpai 🇮🇳 @divyaa24 Vote now and vote for #preeclampsia #nephjc | |
Nephrology Journal Club @NephJC T2b Derivation cohort 💠299🤰→220 included (79 sPE on admission) 🌟 Majority Caucasian (47.7%) 🌟69/220 had sPE over 2 w (31.36%) 🔥sFlt-1:PIGF ratio ~ 200 in those who went on to develop severe PE vs 6 in those who did not ! ( p<0.001) #NephJC https://t.co/cHFWMu0jXI | |
Elba Medina @elbaonelida RT @NephJC: Are you ready for results? To highlight the importance, keep in mind all the nasty PE outcomes 👇Here is a pic for emphasis #NephJC https://t.co/HbIEPrBu5U | |
Mario Alamilla-Sánchez @MarioAlamilla RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
Nephrology Journal Club @NephJC T2c : sFlt-1:PlGF ratio >40 had 81% sensitivity (95% CI, 70 to 90) 81% specificity (95% CI, 74 to 87) PPV of 66% (95% CI, 55 to 76) NPV of 90%(95% CI, 84 to 95) 🤩 Ratio >40 further tested in validation cohort #NephJC | |
Elba Medina @elbaonelida RT @NephJC: T2b Derivation cohort 💠299🤰→220 included (79 sPE on admission) 🌟 Majority Caucasian (47.7%) 🌟69/220 had sPE over 2 w (31.36%) 🔥sFlt-1:PIGF ratio ~ 200 in those who went on to develop severe PE vs 6 in those who did not ! ( p<0.001) #NephJC https://t.co/cHFWMu0jXI | |
Milagros Flores @dra_miliflores @DrPallaviPrasad So nice 😊 to see ya ☺️☺️☺️#NephJC | |
Nephrology Journal Club @NephJC T2d : For .the validation cohort 🚺 N=556 🤰🏼 Baseline characteristics similar to derivation cohort 🌸 sPE incidence @ 2w = 33.5% (close to % in derivation cohort)#NephJC https://t.co/1KUbbq1Iil | |
Dr Kavita Vishwakarma @Kavitasv20 @divyaa24 What I could conclude looking at all those studies was that we could actually do better with a wider availabilty of this tests in obstretrics clinics.I came across someting as GESTOSIS score which they routinely do in India for PE screening and assess its severity! #NephJC | |
Shreshta Tripathi @ShreshtaT ⬆️antiangiogenic factor soluble fms-like tyrosine kinase 1 (sFlt-1) ⬇️ placental growth factor (PlGF), Landmark trial- PRAECIS trial has taken the Neph-OB/GYN world by 🌪️ @Kavitasv20 @elbaonelida @NephJC #NephJC | |
Nephrology Journal Club @NephJC T2e: Median sFlt-1:PlGF ratios approx. 40 times higher in 🤰🏼who developed sPE than those who did not (291 [IR, 121 to 777] vs 7 [IR, 3 to 40] ; P<0.001) Absolutely mind blowing! 🤯 When test confined to only 1st or last enrollment per 🤰#NephJC https://t.co/5rliospFWQ | |
Shreshta Tripathi @ShreshtaT RT @NephJC: T0c: T0c: Don't take preeclampsia easy! 💔It comes with scary outcomes: higher CV burden, CKD .you'd naively say, for more than 50% of 🌐 population, but think twice, because there are also risks for the 👶#NephjC ✍️by @divyaa24 @silvishah @ASNKidney360 https://t.co/qyEFbptmzD https://t.co/yosQvDkx6K | |
Nephrology Journal Club @NephJC T2f: Overall, sFlt-1:PlGF ratio > 40 pg/ml had: 94% sensitivity (95% CI, 89 to 96) 75% specificity (95% CI, 70 to 79) 65% PPV (95% CI, 59 to 71) 96% NPV (95% CI, 93 to 98) for the primary outcome. #NephJC | |
Dr Kavita Vishwakarma @Kavitasv20 @NephroSeeker @divyaa24 And when people ask, I tell them this is why we need to advocate for women! #NephJC | |
Dr Kavita Vishwakarma @Kavitasv20 RT @ShreshtaT: ⬆️antiangiogenic factor soluble fms-like tyrosine kinase 1 (sFlt-1) ⬇️ placental growth factor (PlGF), Landmark trial- PRAECIS trial has taken the Neph-OB/GYN world by 🌪️ @Kavitasv20 @elbaonelida @NephJC #NephJC | |
Shreshta Tripathi @ShreshtaT #NephJC | |
sejal kotwani @KotwaniSejal RT @Kavitasv20: @divyaa24 What I could conclude looking at all those studies was that we could actually do better with a wider availabilty of this tests in obstretrics clinics.I came across someting as GESTOSIS score which they routinely do in India for PE screening and assess its severity! #NephJC | |
Nephrology Journal Club @NephJC T2g: 💠 In🤰with chronic HT(n=313), the ratio 40 had a PPV of 59%, NPV of 94% In Black🤰🏿(n=169), the ratio 40 had a PPV 66%, NPV of 99% Race-specific multiples of the median of the sFlt-1:PlGF ratio were also higher for Black 🤰🏿 compared with White 🤰or Asian🤰#NephJC | |
Dr Kavita Vishwakarma @Kavitasv20 @divyaa24 https://t.co/LU9tRY27Fo #NephJC | |
Shreshta Tripathi @ShreshtaT 🤢 The not-so-Bright disease of pregnancy?! | |
Nephrology Journal Club @NephJC @ShreshtaT @Kavitasv20 @elbaonelida welcome to #nephjc asia | |
Nephrology Journal Club @NephJC T2i: Looking at maternal adverse outcomes 🤱 - 51 🤱outcomes seen in 556🤰🏽 - The ratio for🤰🏽with adverse outcomes was 10 times ⬆️than for who did not have them. - Adverse🤱 more with a ratio ≥40 -RR for the ratio ⬆️ in🤰with low plt or High liver enzymes #NephJC https://t.co/4YSxFoFabn | |
Nephrology Journal Club @NephJC T2j: Adverse fetal & neonatal 👶 outcomes - Ratio 30x ⬆️with adverse fetal & neonatal outcome - Composite adverse fetal & neonatal outcomes ⬆️with ratio ≥ 40 -8 out of 9 fetal deaths in those with ratio ≥40 -22% ⬆️ incidence of SGA when ratio>40 #NephJC https://t.co/TD2DtE5Qm9 | |
Elba Medina @elbaonelida RT @Kavitasv20: @divyaa24 What I could conclude looking at all those studies was that we could actually do better with a wider availabilty of this tests in obstretrics clinics.I came across someting as GESTOSIS score which they routinely do in India for PE screening and assess its severity! #NephJC | |
Nephrology Journal Club @NephJC T2k: 💠 An inverse dose-response relationship between ratio at enrollment and delivery interval 🗓️ seen whether presented as quartiles or as continuous variable #NephJC https://t.co/6Lrbgz3Tzy | |
Nephrology Journal Club @NephJC T3a: Thus, sFLT-1:PIGF ≥ 40 in 🤰🏽 🏥 with hypertensive disorders of ➡️ higher risk of developing sPE in next 2w ➡️ higher risk of Maternal 🤱& Neonatal 🧑 adverse outcomes #NephJC | |
Nephrology Journal Club @NephJC T3b: Study results led to US FDA clearance of the assay for risk assessment & management of 🤰🏽 with preeclampsia 🇺🇲 🇮🇳 its awaited still #NephJC https://t.co/rnYrrVpTIM | |
Dr Kavita Vishwakarma @Kavitasv20 @NephJC @NephroSeeker @KIReports @NephroSeeker I gotta learn so much from you! #NephJC | |
Dr Nikhil J @DrNikhilJ1 @NephJC That's 😳 #NephJC | |
Nephrology Journal Club @NephJC T3c Strength 💪 #NephJC Demographically diverse cohort 🤰🏻Multicenter Blinded trial 🧑🦯 | |
Shreshta Tripathi @ShreshtaT @NephJC “on Wednesdays we #NephJc! “ 😂💃 https://t.co/yKqLCZXuX9 | |
Milagros Flores @dra_miliflores @NephJC #NephJC https://t.co/2biUv5AWzq | |
Nephrology Journal Club @NephJC T3d Limitations #NephJC 🚫 Exclusion of 🤰 multiple preg and High risk cases for PE like APLA who are on heparin excluded 🚫 🚫Did not address outpatient with PE - missed opportunity? | |
Pallavi Prasad MD DNB @DrPallaviPrasad @dra_miliflores Hi Mili ! Already missing our "pod-o-cyte "#NephJc https://t.co/F7fFdgvShI | |
shahin mohammed @shahsonride RT @NephJC: T3a: T3a: Thus, sFLT-1:PIGF ≥ 40 in 🤰🏽 🏥 with hypertensive disorders of ➡️ higher risk of developing sPE in next 2w ➡️ higher risk of Maternal 🤱& Neonatal 🧑 adverse outcomes #NephJC | |
Pallavi Prasad MD DNB @DrPallaviPrasad @NephJC Still can't figure out why not OPD pre eclampsia patients and why not 20-22 weeks ? Does anyone know why? 🤨 #NephJc | |
shahin mohammed @shahsonride RT @ShreshtaT: ⬆️antiangiogenic factor soluble fms-like tyrosine kinase 1 (sFlt-1) ⬇️ placental growth factor (PlGF), Landmark trial- PRAECIS trial has taken the Neph-OB/GYN world by 🌪️ @Kavitasv20 @elbaonelida @NephJC #NephJC | |
Nephrology Journal Club @NephJC Will this study change your practice? Do u have access to sFLT-1/PIGF ratio in ur setting? #NephJC | |
Jose Hernandez @Pharma_Mty RT @NephJC: T0g: T0g: About the most common GN in the world and preeclampsia... Don't take our word for granted! We just mention, that the same thing was said in @ISGDtweets podcast #NephMadness #NephJC 🎙️Hear it yourself from @kdjhaveri @koyaljainMD @anna_burgner https://t.co/y1oiJiJrLb | |
Pallavi Prasad MD DNB @DrPallaviPrasad @NephroSeeker @divyaa24 I think i got the same reaction from my own self when I read it 😁🫣🤦 let's spread the word @womeninnephro @WomenNeph_india #NephJC | |
Anant SSP MD DM 🇮🇳 @Glomkeeper RT @NephJC: T1e : T1e : Primary endpoint was development of severe PE (sPE) within two weeks of enrollment 📈 To know what sPE means, take a glance at this amazing infographic by @elbaonelida ! #NephJC https://t.co/qOciMn8ZYy | |
Nephrology Journal Club @NephJC T3e Future research & therapeutics - Interrupting the sFlt-1 pathway could slow disease progression & prolong pregnancy ➡️ Potential PE treatment : PlGF administration, being studied in 🐀models Therapeutic removal of sFlt-1 from 🤰circulation in early studies👭 #nephjc | |
Dr Nikhil J @DrNikhilJ1 @kidneyrebel @AndreaOliverio Just in time #NephJC https://t.co/wgLVM9Vwha | |
Pallavi Prasad MD DNB @DrPallaviPrasad @NephJC Not yet. Considering cost as a limitation. We need more research in the area to know how to best use it #NephJc | |
Dr Kavita Vishwakarma @Kavitasv20 @arvindcanchi @NephJC @ba_roopa It would be interesting to do a similar study on our poplulation. The ratio fared far better than the clinical indices in the trial and the whole point is to antedate Preeclampsia before end organ damage sets in. Are we actually diagnosing it late when signs appears! #NephJC | |
Nephrology Journal Club @NephJC Any final thoughts ? #nephjc | |
Nephrology Journal Club @NephJC Thanks for joining us today and for contributing to this rich discussion, and a special thank you to our @nephjc team @DrPallaviPrasad @drpriyajohn @sabarivenus @NephroSeeker Make sure you have submitted ur #nephmadness brackets*2 This is @divyaa24 your host signing out #NephJC | |
Dr Kavita Vishwakarma @Kavitasv20 @DrPallaviPrasad @NephJC I asked several OBG/ Gynae friends and they said they haven't used it in their clinical practice yet. #NephJC | |
Milagros Flores @dra_miliflores @NephJC Advocacy will open the door !!! Need more programs to gain confidence on NephroObstetrics #NephJC, educate and re-educate myths about nephrology and obstetrics!!! https://t.co/k428akPGa8 | |
Dr Kavita Vishwakarma @Kavitasv20 @DrPallaviPrasad @NephJC That's a valid question. It means there coudl be missed cases. Even I couldn't understand why! #NephJC | |
Silvi Shah, MD, MS @silvishah RT @NephJC: T0c: T0c: Don't take preeclampsia easy! 💔It comes with scary outcomes: higher CV burden, CKD .you'd naively say, for more than 50% of 🌐 population, but think twice, because there are also risks for the 👶#NephjC ✍️by @divyaa24 @silvishah @ASNKidney360 https://t.co/qyEFbptmzD https://t.co/yosQvDkx6K | |
Milagros Flores @dra_miliflores @NephJC @DrPallaviPrasad @drpriyajohn @sabarivenus @NephroSeeker @divyaa24 #NephJC @divyaa24 @NephroSeeker @DrPallaviPrasad @sabarivenus @drpriyajohn https://t.co/SaGTfnm66P | |
Dr Kavita Vishwakarma @Kavitasv20 @DrPallaviPrasad @NephroSeeker @divyaa24 @womeninnephro @WomenNeph_india I had to check it on internet, Honestly even I was not aware! 😁 #NephJC | |
Pallavi Prasad MD DNB @DrPallaviPrasad @dra_miliflores Why can't I find out pod GIF? #NephJC @NephroSeeker do share it here | |
Milagros Flores @dra_miliflores @NephroSeeker @divyaa24 $ 73.81 vrs 68.21 euros … hope my conversor is correct !!! #NephJC | |
Pallavi Prasad MD DNB @DrPallaviPrasad @NephroSeeker @dra_miliflores Pod-o-cyte rocks @dra_miliflores @sabarivenus 🤘#NephJC ...Many of us still here 🤩 | |
Milagros Flores @dra_miliflores @NephroSeeker @divyaa24 Never used it… but surely can start… Have a couple of pregnant KT on follow up!! Yesterday met one of there babies, thanks no complications until now !!! #NephJC | |
Milagros Flores @dra_miliflores So nice to see podmates, friends and family at #NephJC Morning is still on… and practice must go on !!! 🙂 #nefroneando 🙂 | |
Beth Taber-Hight @taberhight RT @NephJC: T2e: T2e: Median sFlt-1:PlGF ratios approx. 40 times higher in 🤰🏼🤰🏼 who developed sPE than those who did not (291 [IR, 121 to 777] vs 7 [IR, 3 to 40] ; P<0.001) Absolutely mind blowing! 🤯 🔥 When test confined to only 1st or last enrollment per 🤰🏼 the results were Ditto! #NephJC https://t.co/fVvrgtY46e | |
Sonal Asthana, MD @sonalasthana RT @divyaa24: ASIAN DATA sFlt-1/PlGF ratio cutoff of 38 demonstrated clinical value for the short-term prediction of preeclampsia in Asian women with suspected preeclampsia, potentially helping to prevent unnecessary hospitalization and intervention. https://t.co/ZXUSUeBL7U #nephjc | |
miguel angel franco @83_kelimig RT @NephJC: T2j: T2j: Adverse fetal & neonatal 👶 outcomes 💠 Ratio 30x ⬆️in 🤰🏽with adverse fetal & neonatal outcome 💠 Composite adverse fetal & neonatal outcomes ⬆️with ratio ≥ 40 💠 8 out of 9 fetal deaths in those with ratio ≥40 💠 22% ⬆️ incidence of SGA when ratio>40 #NephJC https://t.co/X7ZJicTbOj | |
Tanja Dudenbostel, MD, FASH, FAHA @DrDudenbostel RT @hswapnil: #HypHIP nicely timed with #NephMadness #PreEclampsiaRegion Diagnosis (and #NephJC tonight!) | |
Roberto Gutiérrez @DrRobertoGuti RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
Roberto Gutiérrez @DrRobertoGuti RT @NephJC: T0e: T0e: Pathophysiology of pre-eclampsia ⚖️Central event is imbalance between angiogenic and antiangiogenic factors #NephJC 👇The overview of pre-eclampsia pathogenesis from @ASNKidney360 ✍️By @divyaa24 @silvishah @NephroSeeker @DrSandiDumanski 🔗https://t.co/qyEFbptmzD https://t.co/p3Prda7d5A | |
SB @sbABetterLeader RT @divyaa24: Today I was taking a lecture for MD med students When I told them #preeclampsia is the most common GN Everyone was surprised We should be teaching more OBSTETRIC NEPHROLOGY in MBBS/MD #nephjc | |
pADQI @adqi_p RT @NephJC: T2j: T2j: Adverse fetal & neonatal 👶 outcomes 💠 Ratio 30x ⬆️in 🤰🏽with adverse fetal & neonatal outcome 💠 Composite adverse fetal & neonatal outcomes ⬆️with ratio ≥ 40 💠 8 out of 9 fetal deaths in those with ratio ≥40 💠 22% ⬆️ incidence of SGA when ratio>40 #NephJC https://t.co/X7ZJicTbOj | |
Manuel Marquez (he/him) 👨🏻⚕️🇲🇽 🥗 @Kidney_Power RT @NephJC: T0a: T0a: Let’s start with a brief introduction of key facts in pre-eclampsia. ✍️ In a nutshell, here is a beautiful 🪧 infographic by @nephroseeker @KIreports #NephJC https://t.co/6JNeWOKxYu | |
Andrew Michael South, MD, MS @asouth_neph Hey #NephJC @NephJC #NephMadness folks Want to learn more about #Preeclampsia? Join us NOW for the @AHAScience @KidneyInCVD Webinar https://t.co/bRwxPKZQV0 | |
Carmen De Miguel, PhD, MS, FAHA @Carmendemigue12 RT @asouth_neph: Hey #NephJC @NephJC #NephMadness folks Want to learn more about #Preeclampsia? Join us NOW for the @AHAScience @KidneyInCVD Webinar https://t.co/bRwxPKZQV0 | |
shahin mohammed @shahsonride RT @anna_burgner: In other words, why it is SO important to make sure you are asking your patients about this in their past medical history! #NephJC | |
vojdanian mahdi @nobandegan RT @JasmineNephro: 🤰Hypertensive disorders of pregnancy @NephJC 👇 | |
soda_troubles,https://med-mastodon.com/@haysam @set_fortess RT @divyaa24: ASIAN DATA sFlt-1/PlGF ratio cutoff of 38 demonstrated clinical value for the short-term prediction of preeclampsia in Asian women with suspected preeclampsia, potentially helping to prevent unnecessary hospitalization and intervention. https://t.co/ZXUSUeBL7U #nephjc | |
tun win @TunTunWin121266 RT @drpriyajohn: Hello everyone. This is Priya , Nephrologist and POD 3 captain , joining from Hyderabad, India. No COI except that we see a lot of PE in our centre and the utility of this paper in real world experience gives me hope #NephJC. Will be lurking as i juggle btw morning chores | |
Matthew Sparks, MD @Nephro_Sparks RT @asouth_neph: Hey #NephJC @NephJC #NephMadness folks Want to learn more about #Preeclampsia? Join us NOW for the @AHAScience @KidneyInCVD Webinar https://t.co/bRwxPKZQV0 | |
Jathzibe Rosas @jathzi RT @JasmineNephro: 🤰Hypertensive disorders of pregnancy @NephJC 👇 | |
maria jose vargas @mvargas07 RT @NephJC: T0e: T0e: Pathophysiology of pre-eclampsia ⚖️Central event is imbalance between angiogenic and antiangiogenic factors #NephJC 👇The overview of pre-eclampsia pathogenesis from @ASNKidney360 ✍️By @divyaa24 @silvishah @NephroSeeker @DrSandiDumanski 🔗https://t.co/qyEFbptmzD https://t.co/p3Prda7d5A | |
Jithu Kurian🇮🇳 @Jithukurian6 Jithu kurian from Kerala . No COI. #nephjc | |
diacavan @diacavan RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🫘Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/2pjXo0aDCl https://t.co/Wtmqqpp8aP | |
diacavan @diacavan RT @NephJC: T0c: T0c: Don't take preeclampsia easy! 💔It comes with scary outcomes: higher CV burden, CKD .you'd naively say, for more than 50% of 🌐 population, but think twice, because there are also risks for the 👶#NephjC ✍️by @divyaa24 @silvishah @ASNKidney360 https://t.co/qyEFbptmzD https://t.co/yosQvDkx6K | |
Luis Enrique Alvarez @LuisAlvarezRa RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
Eduardo @Eduardo42937195 RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🔴Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/O0pNWQ7sSn https://t.co/ZJKjSM1OvP | |
ya soy esa señora @monavite RT @NephJC: T0e: T0e: Pathophysiology of pre-eclampsia ⚖️Central event is imbalance between angiogenic and antiangiogenic factors #NephJC 👇The overview of pre-eclampsia pathogenesis from @ASNKidney360 ✍️By @divyaa24 @silvishah @NephroSeeker @DrSandiDumanski 🔗https://t.co/qyEFbptmzD https://t.co/p3Prda7d5A | |
Maribel Merino-López @merlomar2109 RT @NephJC: Check out the STUNNING visual abstracts by @elbaonelida & @divyaa24 https://t.co/RQ3Ss6TR8O… #NephJC https://t.co/lcYiKOxlf3 | |
Verner Venegas @Vernisartan RT @NephJC: T0i: T0i: #NephJC Glomerular endotheliosis= pathognomonic for PE ⚔️ Flt-1 inhibits VEGF 🫘Glom endotheliosis- swollen, vacuolated endothelial cells, swollen mesangial cells, subendothelial prot deposits+ tubular casts Infographic by @Nephroseeker #Kireports https://t.co/2pjXo0aDCl https://t.co/Wtmqqpp8aP | |
Nader @Nader62321135 RT @JasmineNephro: 🤰Hypertensive disorders of pregnancy @NephJC 👇 | |
Abhishek @aksrulz13 RT @edgarvlermamd: GEMRITUX: GEMRITUX: Rituximab for Severe Membranous Nephropathy ca. 2017 from @JASN_News #VisualAbstract by @CristhianMuM #Nephpearls #NephJC 👉🏼 https://t.co/UrC64vPmuH https://t.co/nr984xPkra | |
Abhishek @aksrulz13 RT @edgarvlermamd: Membranous Nephropathy: Membranous Nephropathy: Treatment regimens PRE-MENTOR #Nephpearls #NephJC https://t.co/deVFJis603 | |
Abhishek @aksrulz13 RT @edgarvlermamd: MENTOR: MENTOR: Rituximab (vs Cyclosporine) for Membranous GN ca. 2019 from @NEJM 📌 Non-inferior in inducing complete/ partial remission of proteinuria at 12 months #Nephpearls #NephJC 👉🏼 https://t.co/0iLPPejnqM https://t.co/AufZ5Gn7Jv | |
Anwesha Banerjee @Anwesha17377209 RT @divyaa24: Today I was taking a lecture for MD med students When I told them #preeclampsia is the most common GN Everyone was surprised We should be teaching more OBSTETRIC NEPHROLOGY in MBBS/MD #nephjc | |
Kajaree Giri @KajareeG RT @NephJC: T1b: T1b: Recapping how preeclampsia and other hypertensive disorders of pregnancy were defined by @ACOGPregnancy ❣️Remider: proteinuria is not mandatory for PE diagnosis #NephJC https://t.co/902pUGrUxC | |
Kajaree Giri @KajareeG RT @NephJC: T0c: T0c: Don't take preeclampsia easy! 💔It comes with scary and unwanted outcomes: higher CV burden, CKD ... you'd naively say, for more than 50% of 🌐 population, but think twice, because there are also risks for the 👶 #NephjC @ASNKidney360 https://t.co/qyEFbptmzD https://t.co/2r76VoCs4R |
#NephJC content from Twitter.